electroCore receives two new US patents for nerve stimulation technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
electroCore Expands Intellectual Property Portfolio
March 30, 2026 8:01 AM EDTROCKAWAY, N.J., March 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the issuance of two new U.S. patents that further bolster the Companys already extensive intellectual property portfolio. These additions underscore electroCores position as a leader in non-invasive vagus nerve stimulation (nVNS) technology and demonstrate how a nimble small-cap innovator can build one of the most robust patent portfolios in the field. The newly issued patents are:
U.S. Patent No. 12,208,263, entitled Devices and Methods for Vagal Nerve Stimulation was issued on... More
